Please login to the form below

Not currently logged in
Email:
Password:

hepatitis C

This page shows the latest hepatitis C news and features for those working in and with pharma, biotech and healthcare.

New leader at Medivir after setbacks

New leader at Medivir after setbacks

Meanwhile, last year Johnson &Johnson ducked out of a partnership on a hepatitis C virus programme after deciding the market opportunity wasn’t sufficiently attractive.

Latest news

More from news
Approximately 104 fully matching, plus 275 partially matching documents found.

Latest Intelligence

  • The race for an HIV ‘cure’ The race for an HIV ‘cure’

    Most of our medicines in Europe are available at the same time, at generic prices, in Africa – in hepatitis C, the drugs are available earlier in Africa than Europe because of

  • The NHS and ABPI at 70: inching closer to the triple win The NHS and ABPI at 70: inching closer to the triple win

    Meanwhile, the pharma industry is hitting new heights in drug innovation, including cures for diseases such as hepatitis C, haemophilia and huge progress in cancer and cell and gene therapy - but

  • Uncertainty, austerity and Brexit Uncertainty, austerity and Brexit

    on hepatitis C treatments and the recent introduction of the Budget Impact Test.

  • No incentive for a cure No incentive for a cure

    Hepatitis C virus treatments like Maviret from AbbVie, which cures people with hard-to-treat genotype 3 after an 8. ... This is the route the NHS in the UK has taken with innovative hepatitis C treatments; it will only pay for the medication if a patient

  • IQVIA: The High IQ Approach of Human Data Science IQVIA: The High IQ Approach of Human Data Science

    Therapeutic advances during that same period have been remarkable; who would have thought we’d find a cure for hepatitis C, or see immunotherapy transform outcomes in cancer care?

More from intelligence
Approximately 3 fully matching, plus 35 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest from PMHub

  • Hanson Zandi

    BPH. Cardiovascular. Consumer health and nutrition. Contraception. Dermatology. Diabetes. GORD. Hepatitis C.

  • Access and elimination: the future of DAAs in hepatitis C

    Access and elimination: the future of DAAs in hepatitis C. Published in Pharmaphorum January 2017. ... The arrival of interferon-free, orally administered direct-acting antivirals (DAAs) in 2014 was a leap forward for the treatment of hepatitis C (HCV),

  • Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

    Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America. ... If left untreated, hepatitis C leads to chronic health problems putting a huge strain on national healthcare resources.

  • 90TEN nominated for five Communiqué Awards

    The agency’ s Hepatitis C medical education programme for AbbVie, ‘ Revealing a New Face of Cure’, has been shortlisted for Excellence in Communications via a Live Event or Stand Alone Activity.

  • Atlantis Healthcare

    haemophilia. hepatitis C. incontinence. multiple sclerosis. osteoporosis . rheumatoid arthritis. Additionally, Atlantis has delivered many programmes to support rare diseases, health screening and blood donor management.

More from PMHub
Approximately 4 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe’s leading hub for life sciences innovation...

Infographics